<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910927-0026</DOCNO><DOCID>910927-0026.</DOCID><HL>   Technology Brief -- Sanofi Inc.:   Genetic Systems Test Kit   Gets License From FDA</HL><DATE>09/27/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B4</SO><CO>   ELF F.SAN</CO><MS>CONSUMER NON-CYCLICAL (NCY)TECHNOLOGY (TEC)</MS><IN>DRUG MANUFACTURERS (DRG)MEDICAL andamp; BIOTECHNOLOGY, GENETIC RESEARCH, PROSTHETICS (MTC)</IN><GV>FOOD AND DRUG ADMINISTRATION (FDA)</GV><RE>EUROPE (EU)FRANCE (FR)NORTH AMERICA (NME)NEW YORK (NY)UNITED STATES (US)WESTERN EUROPE (WEU)</RE><LP>   The Food and Drug Administration has licensed the firstcombination test kit designed to detect antibodies to bothstrains of human immunodeficiency viruses that cause AIDS.   The agency said the Genetic Systems Corp. kit couldstreamline testing procedures for blood banks and otherinstitutions engaged in high-volume screening and furtherimprove the overall safety of the U.S. blood supply.Seattle-based Genetic Systems is a subsidiary of Sanofi Inc.,New York.</LP><TEXT>   Antibody tests for human immunodeficiency virus type 1, orHIV-1, were licensed in 1985 and are universally used byblood banks. An antibody test for the extremely rare HIV-2,also developed by Genetic Systems, was licensed in 1990, butisn't widely used because of limited bloodbank resources.   &quot;A combination test may encourage more widespread testing&quot;for HIV-2, said FDA Commisioner David Kessler.</TEXT></DOC>